Latest News
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
31 December 2025 - US-based digital health company Profusa, Inc. (NASDAQ: PFSA), which develops tissue-integrated biosensors for continuous biochemical monitoring, said on Wednesday that it has signed a distributor partnership with French medical dev...
Delcath publishes Phase 3 FOCUS subgroup data supporting HEPZATO in metastatic uveal melanoma
31 December 2025 - Oncology company Delcath Systems Inc (Nasdaq: DCTH) disclosed on Wednesday that it has published subgroup analyses from its phase 3 FOCUS study evaluating the Melphalan/Hepatic Delivery System in patients with unresectable metastat...
Corcept announces receipt of FDA Complete Response letter for relacorilant in hypercortisolism
31 December 2025 - Corcept Therapeutics Incorporated (NASDAQ: CORT) reported on Wednesday that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for relacorilant as a treatment fo...
Axsome Therapeutics secures FDA priority review for AXS-05 in Alzheimer's disease agitation
31 December 2025 - New York-based biopharmaceutical company Axsome Therapeutics, Inc. (NASDAQ: AXSM) said on Wednesday that the US Food and Drug Administration has accepted for filing its supplemental New Drug Application for AXS-05 for Alzheimer...
Sensiva Health names new chief operating officer
31 December 2025 - Sensiva Health, an infection prevention and precision medicine-driven healthcare solutions company, announced on Tuesday the appointment of Donovan Blakney as chief operating officer (COO), effective immediately.In this role, Blakn...